Search clinical trials for: LY2940094

Total 4 results

BlackThorn Therapeutics, Inc.

Completed

A Study of LY2940094 in Major Depressive Disorder

Major Depressive Disorder

Canada
BlackThorn Therapeutics, Inc.

Completed

Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)

Major Depressive Disorder

United States
BlackThorn Therapeutics, Inc.

Completed

A Study of Nociceptin/Orphanin FQ Peptide Receptor Occupancy in Healthy Subjects

Depression

Canada
BlackThorn Therapeutics, Inc.

Completed

A Study of LY2940094 in Participants With Alcohol Dependency

Alcoholism

United States

3

Subscribe